000 01446 a2200421 4500
005 20250518035012.0
264 0 _c20200226
008 202002s 0 0 eng d
022 _a1872-8332
024 7 _a10.1016/j.lungcan.2019.03.031
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aYan, Sherry X
245 0 0 _aStereotactic body radiation therapy with higher biologically effective dose is associated with improved survival in stage II non-small cell lung cancer.
_h[electronic resource]
260 _bLung cancer (Amsterdam, Netherlands)
_c05 2019
300 _a147-153 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAged
650 0 4 _aAged, 80 and over
650 0 4 _aCarcinoma, Non-Small-Cell Lung
_xmortality
650 0 4 _aFemale
650 0 4 _aFollow-Up Studies
650 0 4 _aHumans
650 0 4 _aLung Neoplasms
_xmortality
650 0 4 _aLymphatic Metastasis
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aNeoplasm Staging
650 0 4 _aRadiosurgery
_xmethods
650 0 4 _aRadiotherapy Dosage
650 0 4 _aSurvival Analysis
650 0 4 _aTreatment Outcome
700 1 _aQureshi, Muhammad M
700 1 _aDyer, Michael
700 1 _aTruong, Minh Tam
700 1 _aMak, Kimberley S
773 0 _tLung cancer (Amsterdam, Netherlands)
_gvol. 131
_gp. 147-153
856 4 0 _uhttps://doi.org/10.1016/j.lungcan.2019.03.031
_zAvailable from publisher's website
999 _c29630424
_d29630424